d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund

d) Company A says that it has provided 138 patents, of which 45 were successful, giving a success rate of 32.6%. The corresponding figure for Company B is 30.7%. How would Company B respond to this claim? O A. Company B would respond that Company A's overall success rate is greater because Company A has submitted a higher volume of patent requests. O B. Company B would respond that Company A's overall success rate is greater because Company A's patent requests are subjected to a more lenient approval process. O C. Company B would respond that Company A's overall success rate is greater because it focuses on anti-inflammatory drug patents whose overall success rate is higher than the success rate for other drug patents. O D. Company B would respond that Company A's overall success rate is greater because Company B has yet to submit a new batch of patent requests for which it expects a high success rate for all drug types. e) (i) If the pharmaceutical company wants to buy a patent, which biotechnology company is better for genetic disease drugs? The pharmaceutical should buy the patent from Company because it has a success rate with genetic disease drugs of which is greater than the other company. (Deund

MATLAB: An Introduction with Applications

6th Edition

ISBN:9781119256830

Author:Amos Gilat

Publisher:Amos Gilat

Chapter1: Starting With Matlab

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

3(5x)
Diagonalize the matrices in Exercises 7-20, if possible. The roul eigenvalues for Exercises 11-16 and 18 are included below the matrix.
6 ÷ 2(1+2) =
16 a 104
28 2.
(8/5)-2
25 .25 2. 2n
12.6
6
2b – 3b²